BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Drug Development

  Long-Term Phase 3 Study Shows Esketamine Nasal Spray Plus an Oral Antidepressant Delayed Time to Relapse in Patients with Treatment-Resistant Depression

  A separate Phase 3 study provides evidence that esketamine was generally well tolerated with no new safety signals with up to 52 weeks of dosing for patients with treatment-resistant depression

  May 31, 2018

   · 

  14 min read
• Policy

  Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities

  Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities

  May 31, 2018

   · 

  9 min read
• FDA

  Medicrea Receives World’s First and Only FDA-Clearance to Market Patient-Specific Cages

  The Medicrea® Group announced that it has obtained the first and only 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market patient-specific spinal cages through the extension of its UNiD™ technology to select from its IB3D™ range of 3D-printed titanium interbody devices.

  May 31, 2018

   · 

  4 min read
• Biotech Beach

  Denovo Biopharma to Participate in Jefferies 2018 Global Healthcare Conference

  Denovo Biopharma LLC announced that Wen Luo, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Michael Haller, Ph.D., Chief Financial Officer, will be meeting with investors at the Jefferies 2018 Global Healthcare Conference.

  May 31, 2018

   · 

  1 min read
• Biotech Beach

  BioPhotas Inc. Introduces the Celluma POD Light Therapy Device

  BioPhotas, Inc. announced today the introduction of the latest addition to the Celluma Series, the Celluma POD.

  May 31, 2018

   · 

  2 min read
• Business

  Future Now Detox Earns Joint Commission Accreditation

  Future Now Detox is a proud recipient of Joint Commission Accreditation.

  May 31, 2018

   · 

  3 min read
• Business

  Michelle Obama revealed as Keynote Speaker at BOLD 2018, the MINDBODY Conference

  MINDBODY announced that former First Lady, Michelle Obama, will join MINDBODY’s CEO and co-founder, Rick Stollmeyer, for a fireside chat during the company’s annual BOLD conference.

  May 31, 2018

   · 

  3 min read
• Drug Development

  Windtree Therapeutics’ Aerosolized KL4 Surfactant Preclinical Data in Influenza Presented at the 2018 American Thoracic Society Meeting

  Windtree Therapeutics, Inc. announced that data from a previously released preclinical influenza study was presented at the 2018 American Thoracic Society (ATS) meeting held in San Diego.

  May 31, 2018

   · 

  6 min read
• Biotech Beach

  Five Prime Therapeutics to Present at Jefferies 2018 Global Healthcare Conference

  Five Prime Therapeutics, Inc. announced that Francis Sarena, Chief Strategy Officer, will present at the Jefferies 2018 Global Healthcare Conference.

  May 31, 2018

   · 

  1 min read
• Drug Development

  Northern Biologics’ MSC-1 Enters the Clinic

  Northern Biologics Inc. announced that its lead immuno-oncology antibody, MSC-1, began clinical testing at Memorial Sloan Kettering Cancer Center with plans to soon expand to other world-leading sites in Canada and Europe.

  May 31, 2018

   · 

  3 min read